Theodore R. Schroeder - Dec 28, 2021 Form 4 Insider Report for Nabriva Therapeutics plc (NBRV)

Role
Chief Executive Officer, Director
Signature
/s/ Daniel Dolan, by power of attorney
Stock symbol
NBRV
Transactions as of
Dec 28, 2021
Transactions value $
$57,320
Form type
4
Date filed
12/29/2021, 08:32 PM
Previous filing
Dec 8, 2021
Next filing
Jan 4, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NBRV Ordinary Shares Purchase $57.3K +100K +44.27% $0.57 326K Dec 28, 2021 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.5685 to $0.5750, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price.